Treatment with compound PI-7 increased FOXO3 protein levels, reduced NF-κB, and diminished the levels of inflammatory cytokines belonging to the cytokine storm in COVID-19 patients (see Fig. 5B). Here, NFKB1 is linked to COVID-19.